IL18 and melanoma: The presence of an inflammatory response in the B16 melanomas treated with LTX-315 was further indicated by increased mRNA levels of inflammatory cytokines such as interleukin (IL) 1β, IL6 and IL18 in the tumor tissue and of IL6 in plasma samples.